Desensitization for Highly Sensitized Recipients of Pancreas Transplantation

Completed

Conditions studied: Type 1 Diabetes, Rejection of Pancreas Transplant, Desensitization

In brief

This is an observational study for patients with type 1 diabetes, whom are already scheduled to have desensitization treatment to help increase the chance of receiving a pancreas transplant.The study staff will be looking at medical records in order to collect past, present and future information for each subject's medical condition and/or transplant. There are no additional study tests, procedures or devices needed for our analysis.

Key facts

Study ID

NCT00867386

Run by

Northwestern University

People needed

7

Starts

2006-12-01

Expected to finish

2013-10-01

Last updated by the study team

2014-03-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pancreas transplant recipients with elevated panel reactive antibody levels of >50% and who have received desensitization treatment and subsequently receive their transplantation at Northwestern Memorial Hospital (NMH).

You may not qualify if…

• No Exclusion criteria exist.

Where it is running

• Northwestern University — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.